Effect of L-Carnitine Supplementation in Preterm Neonates
ConditionRespiratory Distress Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-24
SponsorMuhammad Aamir Latif
About this trial
The current study is planned to see the effect of L-carnitine supplementation in preterm neonates suffering from RDS among the local population, as there is no such evidence available for the local population and there are conflicting statistics regarding the discharge rate of these neonates.
Eligibility criteria
Qualifiers
Preterm neonates
Either gender
With RDS
Admitted to the neonatal intensive care unit (NICU) within 24 hours of birth .
Disqualifiers
Neonates with gastrointestinal tract (GIT) anomalies
With confirmed or suspected sepsis at the time of enrollment
Neonates whose clinical condition contraindicates study participation (e.g., expected survival <48 hours, as judged by the neonatologist).
Trial design
Treatments tested in this trial
- L-carnitine
- Standard care
Treatment groups
160 Participants
are divided into 2 treatment groupsSponsors and collaborators
Muhammad Aamir Latif
Lead sponsor
RESnTEC, Institute of Research
Sponsor institution
Source ClinicalTrials.gov